| Literature DB >> 26400620 |
Chao-Kai Hsu1,2,3, Ryo Saito1,4, Arti Nanda5, Ellie Rashidghamat1, Hejab Al-Ajmi5, Julia Yu-Yun Lee2, Michihiro Hide4, John A McGrath1.
Abstract
Naevus sebaceus has recently been shown to result from post-zygotic mutations in HRAS, KRAS or occasionally NRAS. We present details of a neonate with extensive naevus sebaceus in whom we identified a pathogenic mutation in HRAS (c.37G > C; p.Gly13Arg), but only in lesional skin DNA, consistent with a mosaic RASopathy. This case highlights the clinicopathological and molecular findings of this naevoid disorder as well as the key issues in the clinical assessment and management of such patients.Entities:
Keywords: HRAS; RASopathy; Schimmelpenning-Feuerstein-Mims syndrome; naevus sebaceus
Mesh:
Substances:
Year: 2015 PMID: 26400620 DOI: 10.1111/ajd.12399
Source DB: PubMed Journal: Australas J Dermatol ISSN: 0004-8380 Impact factor: 2.875